Unity Software (NYSE: U) stock closed out last week's trading with big gains thanks to bullish coverage from an analyst. The company's share price ended this Friday's trading up 25.7% from the ...
UNITY Biotechnology, Inc. has announced that it will present data from its ASPIRE Phase 2B study on its senolytic candidate, UBX1325, targeting diabetic macular edema at the upcoming ARVO 2025 Annual ...
Unity stock got a big boost from bullish analyst coverage this week. Solid gains for the broader market also helped lift Unity's share price. Jeffries is seeing signs that Unity's AI-powered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results